Blogs about: Vectibix
Featured Blog
Takeda submit Japanese NDA for panitumumab in progressed and/or relapse colorectal cancer
Takeda have submitted a New Drug Application to the Ministry of Health Labour and Welfare in Japan for panitumumab in the treatment of patients with progressed and/or relapse colorectal cancer. Takeda… more →
Kinase News
Trends Update -- "Personalized Effectiveness": Amgen Gets Prospective Data to Back KRAS-Vectibix Plan
— 1 comment
Jeremy G wrote 4 months ago: A few weeks ago, when the FDA changed the labeling on anti-EGFR drugs, Amgen was pretty enthusiastic … more →
Trends Update -- Comparative Effectiveness and Personalized Medicine: Genetic Test Identifies Patient Subpopulation for Benefit, Avoids Wasted Money and Time for Others on Erbitux, Vectibix
— 2 comments
Jeremy G wrote 5 months ago: This is exactly how personalized medicine and comparative effectiveness can interact to benefit pati … more →
"Monoclonal antibodies in cancer therapy – significant commercial opportunities with developing technologies and innovative products", Says Visiongain new report explains prospects
visiongainpharmareports wrote 7 months ago: San Francisco, CA and London, UK;Monoclonal Antibodies in Cancer Therapy 2009-2024 Publication date … more →
New Game Plan...
— 11 comments
Stef wrote 1 year ago: I have had many discussions with my oncologist over the last week or so. I have challenged him to b … more →
Takeda submit Japanese NDA for panitumumab in progressed and/or relapse colorectal cancer
crimsoncanary wrote 1 year ago: Takeda have submitted a New Drug Application to the Ministry of Health Labour and Welfare in Japan f … more →
Preemptive Treatment May Significantly Reduce Skin Toxicities in Patients Receiving Panitumumab
crimsoncanary wrote 1 year ago: Data presented today at the 10th World Congress on Gastrointestinal Cancer shows that preemptive tre … more →
Phase III data of Vectibix/FOLFOX confirms safety and efficacy
crimsoncanary wrote 1 year ago: Data presented at ASCO show Vectibix (panitumumab) in combination with FOLFOX is safe and shows effi … more →
BIOTECH STOCKS: 2007 WINNERS AND LOSERS
danielteper wrote 1 year ago: New York, NY based Imclone (NASDAQ:IMCL) spiked 65% in 2007 on the promise of its only drug, Erbit … more →
Vectibix and Chemotherapy, E7389 (Eribulin) for Treatment of Head & Neck Cancer
— 1 comment
bmirtsching wrote 2 years ago: Advances in the management of patients with head & neck cancer (HNC) were presented at the Multi … more →
